• Guggenheim Reiterates "Buy" Rating for Beam Therapeutics (NASDAQ:BEAM)

    Source: Buzz FX / 28 Feb 2025 11:51:14   America/New_York


    Guggenheim Reiterates "Buy" Rating for Beam Therapeutics (NASDAQ:BEAM) Written by MarketBeat February 28, 2025 Share Link copied to clipboard. Beam Therapeutics ( NASDAQ:BEAM - Get Free Report ) 's stock had its "buy" rating reiterated by G
    Read more...
Share on,